ClinDatrix Forms International CRO Consortium

ClinDatrix announced in a press release that it has formed a consortium with six other contract research organizations (CROs). The global collaboration will provide services for clinical trials with each CRO leveraging its country’s language and its experience with local regulatory agencies. The new braintrust will provide pharmaceutical companies a centralized entity with multiple abilities in different countries.

Christophe Tournerie, MD, Founder and CEO of ClinActis, a member CRO, said, “The companies’ strengths and locations are complementary, so together we offer sponsors the services of a large CRO with the proximity to market, personal attention, and responsiveness that each of the collaborating firms provide their clients.”

CRO Consortium

Brian G. Murphy, ClinDatrix Chairman and CFO said that member companies will gain, in addition to the benefits of collaboration, access to ClinDatrix’s clinical research technology including project management, regulatory affairs, and quality assurance services. The six other CRO’s also have distinct specialties, expertise, and experience.

• ClinActis was established in 2009 and is headquartered in Singapore. It stands to benefit from the growing Asia-Pacific region and will provide site management, clinical monitoring, and clinical staffing.
• Dokumeds is a European CRO established in 1995. It supports EU and non-EU investigators and has personnel and facilities in Central Eastern Europe and Russia.
• DOT International is a Tokyo, Japan based company founded in 2006. It provides full-service CRO support including clinical trials and post-marketing studies.
• OnQ Research is located in Johannesburg, South Africa, providing niche services. It facilitates full clinical trials in South Africa and Africa.  
• Research & Development RA S.A. is a Buenos Aires, Argentina-based firm. It provides services throughout Latin America.
• Venn Life Sciences operates in Ireland, Germany, the UK, Netherlands, Russia, and Switzerland. It continues to expand in Europe and it has a technologies division, InnoVenn.

ClinDatrix says that the participants in the new consortium have considerable value to prospective clients, because knowing the language, the customs, and the regulatory environment confers an immediate advantage to clinical investigators wishing to speed investigational drugs towards approval. In support of the effort, ClinDatrix will provide electronic data capture (EDC), LORENZ DocuBridge electronic common technical document (eCTD), SharePoint/Montrium, and Oracle Argus Safety, and is open to adding other technologies and software in the eClinical environment.